A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 173 participants.
Also called NCT07018453
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 173 participants
- Registry
-
NCT07018453
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07018453. Randomized; no masking; primary purpose treatment. Start 2025-07-16 (actual); primary completion 2026-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- SHR-3167
- Intervention (Drug)
- Insulin Degludec
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct07018453- Content hash
b79bd573757c7651606f620d420c417e0deb77a488b2ebae643a4a96d7ae1e5e